Video Library

Working Together on Alzheimer’s Research

Working Together on Alzheimer’s Research

ATRI and ACTC study where the science is moving on Alzheimer's disease [AD] treatment and how to move it faster. ATRI conducts trials and partners with research teams around the United States. It's a network of first-in-class, best-in-class clinical trial experts who...

Working Together on Alzheimer’s Research

Working Together on Alzheimer’s Research

ATRI and ACTC study where the science is moving on Alzheimer's disease [AD] treatment and how to move it faster. ATRI conducts trials and partners with research teams around the United States. It's a network of first-in-class, best-in-class clinical trial experts who...

Biomarkers & How They Help Diagnose Dementia

Biomarkers & How They Help Diagnose Dementia

Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to medication. When combined with other tests,...

ATRI – Preventing Dementia by Preventing Stroke

ATRI – Preventing Dementia by Preventing Stroke

Wall Street Journal has a new video on how Biogen’s Aduhelm is the first approved treatment for early-stage Alzheimer’s patients and that it may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to...

The Problem of Alzheimer’s

The Problem of Alzheimer’s

On June 30, 2021, USC Alzheimer’s Therapeutic Research Institute's Michael Rafii, MD, PhD, and Alzheimer's Clinical Trial Consortium (ACTC) colleague Jason Karlawish, MD, met for a discussion of Karlawish's recent bookThe Problem of Alzheimer's: How Science, Culture,...